Drug intelligence / Profile preview

polar methanolic fraction of hypericum perforatum

Development stage
Preclinical
Lead developer
University of Ioannina
Modality
Small Molecules
Administration
Intravesical, Intravenous, Topical
01

Overview

The polar methanolic fraction (PMF) is a natural product extract derived from *Hypericum perforatum* L. (St. John's Wort) that contains high concentrations of photoactive naphthodianthrones, primarily hypericin and pseudohypericin. It is developed as a natural photosensitizer for use in photodynamic therapy (PDT) and photodynamic diagnosis (PDD). When exposed to specific wavelengths of light, typically around 630 nm, PMF generates reactive oxygen species (ROS) and singlet oxygen, which induce selective oxidative stress and trigger apoptosis in malignant cells. Preclinical studies have demonstrated that PMF exhibits significant photocytotoxicity against human bladder cancer cell lines (including metastatic T24 and low-grade RT4) and leukemic cells (HL-60), often showing efficacy comparable to or exceeding that of clinically approved synthetic photosensitizers like Photofrin.

Other names
hypericum perforatum polar methanolic fractionst. john's wort polar methanolic fractionPMF extract

Beyond the preview

Go deeper on polar methanolic fraction of hypericum perforatum.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on polar methanolic fraction of hypericum perforatum.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call